Stockreport

BioCardia Inc (BCDA) Q3 2024 Earnings Call Highlights: Breakthroughs and Challenges in Cardiac ... [Yahoo! Finance]

BioCardia, Inc.  (BCDA) 
PDF BioCardia Inc ( NASDAQ:BCDA ) has received FDA breakthrough designation for its lead autologous cardiac cell therapy for heart failure, which is also reimbursed by Medi [Read more]